This page was reviewed under our medical and editorial policy by
Henry Krebs, MD, Interventional and Diagnostic Radiologist
This page was reviewed on December 2, 2022.
Cryotherapy, or cryosurgery, is a procedure that freezes and destroys cancer cells using extremely cold liquid nitrogen or argon gas.
Cryosurgery may be used to kill cancer cells on the skin or in the body.
Cryosurgery may be a treatment option for several types of cancer or cancer-related conditions, including:
In some situations, it may be an option for early-stage prostate cancer or liver cancer. Researchers continue to study how this treatment may help patients with other cancers, too.
The cryotherapy procedure, and what it entails, depends on its purpose and the treatment area.
Before cryosurgery, the patient may receive some kind of pain medication. Possible options include:
Prostate cancer patients receiving cryosurgery need to have a catheter (a soft tube) inserted into the bladder before the procedure. The catheter stays in place for about three weeks after the procedure to help empty the bladder while the area heals.
During a skin procedure, the dermatologist applies liquid nitrogen directly to the area using a cotton swab or a spray bottle. When the liquid nitrogen is applied to the skin, the patient may feel some pain, although his or her doctor may likely numb the area with a topical medicine beforehand. The entire procedure lasts a few minutes and is usually performed in a doctor’s office.
After the procedure, the care team may give the patient instructions on how to care for the treated area, such as how to clean and protect the wound. The treated area usually turns into a blister in the hours following the procedure. Over the course of a few weeks, the blister turns into a scab, which eventually falls off.
During a cryotherapy procedure inside the body, the doctor inserts one or more needle-like probes directly through the skin or through a small incision. An imaging device, such as an ultrasound, is used to help guide the probes to the location of the cancer. The extremely cold temperature of the probes freezes and destroys cells in the area. The body’s immune system then works to naturally remove the dead cells. The procedure generally takes one to three hours.
Since cryosurgery is relatively noninvasive compared with many other treatments, it generally requires a short recovery time. In some cases, the patient may need to stay at the hospital overnight after having cryosurgery, but many patients leave the same day.
Compared with regular surgery, cryosurgery is less invasive and typically comes with lower risks of pain, bleeding and other surgical complications.
Another benefit of cryotherapy treatment is that it may be targeted at the cancerous area, causing minimal damage to healthy tissue in the region surrounding the tumor. It may also be used more than once and as part of a larger treatment plan that includes standard options such as surgery, radiation therapy, chemotherapy and hormone therapy.
In very rare cases, men may develop an abnormal tube that forms between the bladder and rectum (fistula) that lets urine flow into the rectum.
Cervical intraepithelial neoplasia is a precancerous condition in the cervix. Risks and side effects from this type of cryosurgery may include:
The benefits of cryosurgery depend on the type of cancer and how far it’s spread. Cryotherapy may target and destroy specific tumors, but it may also miss or leave behind some microscopic cancerous cells. Many times, the procedure may be repeated as needed.
As a treatment for prostate cancer, cryosurgery may only be used on early-stage tumors that haven’t spread outside the prostate. It isn’t considered a first-line treatment for prostate cancer and tends to be used when other treatments, such as radiation therapy, have failed or when patients cannot receive more standard treatments. For example, cryosurgery may be an option for men who are older or who have other health problems that make regular surgery riskier.
Similarly, cryotherapy is only used to treat retinoblastoma when the tumors are small and at the front of the eye. It isn’t considered an appropriate treatment for larger or more widespread tumors.